Rafferty Asset Management, LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1389426
New York, NY
Position in VRDN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,997,719
-$779,351 QoQ
Shares Held
108,749
-23.4% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 215 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. VRDN ranks #62 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | TWST |
Twist Bioscience Corp
|
40,732 | $4,190,508 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,997,719 | 108,749 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,777,070 | 141,977 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,104,220 | 99,750 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,468,842 | 68,065 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,068,239 | 76,412 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,427,181 | 105,874 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,315,643 | 172,960 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,062,310 | 90,651 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,886,124 | 144,975 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,159,611 | 408,887 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,410,253 | 202,491 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,023,620 | 262,296 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,805,093 | 244,014 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,500,997 | 176,926 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,417,949 | 117,013 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,185,293 | 57,791 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||